Seed Sequence-Matched Controls Reveal Limitations of Small Interfering RNA Knockdown in Functional and Structural Studies of Hepatitis C Virus NS5A-MOBKL1B Interaction

Abstract

Hepatitis C virus (HCV) is a widespread human pathogen causing liver cirrhosis and cancer. Similar to the case for other viruses, HCV depends on host and viral factors to complete its life cycle. We used proteomic and yeast two-hybrid approaches to elucidate host factors involved in HCV nonstructural protein NS5A function and found that MOBKL1B interacts with NS5A. Initial experiments with small interfering RNA (siRNA) knockdown suggesting a role in HCV replication led us to examine the interaction using biochemical and structural approaches. As revealed by a cocrystal structure of a core MOBKL1B-NS5A peptide complex at 1.95 Å, NS5A binds to a hydrophobic patch on the MOBKL1B surface. Biosensor binding assays identified a highly conserved, 18-amino-acid binding site in domain II of NS5A, which encompasses residues implicated in cyclophilin A (CypA)-dependent HCV RNA replication. However, a CypA-independent HCV variant had reduced replication in MOBKL1B knockdown cells, even though its NS5A does not interact with MOBKL1B. These discordant results prompted more extensive studies of MOBKL1B gene knockdowns, which included additional siRNAs and specifically matched seed sequence siRNA controls. We found that reduced virus replication after treating cells with MOBKL1B siRNA was actually due to off-target inhibition, which indicated that the initial finding of virus replication dependence on the MOBKL1B-NS5A interaction was incorrect. Ultimately, using several approaches, we found no relationship of the MOBKL1B-NS5A interaction to virus replication. These findings collectively serve as a reminder to investigators and scientific reviewers of the pervasive impact of siRNA off-target effects on interpretation of biological data. IMPORTANCEOur study illustrates an underappreciated shortcoming of siRNA gene knockdown technology. We initially identified a cellular protein, MOBKL1B, as a binding partner with the NS5A protein of hepatitis C virus (HCV). MOBKL1B siRNA, but not irrelevant RNA, treatment was associated with both reduced virus replication and the absence of MOBKL1B. Believing that HCV replication depended on the MOBKL1B-NS5A interaction, we carried out structural and biochemical analyses. Unexpectedly, an HCV variant lacking the MOBKL1B-NS5A interaction could not replicate after cells were treated with MOBKL1B siRNA. By repeating the MOBKL1B siRNA knockdowns and including seed sequence-matched siRNA instead of irrelevant siRNA as a control, we found that the MOBKL1B siRNAs utilized had off-target inhibitory effects on virus replication. Collectively, our results suggest that stricter controls must be utilized in all RNA interference (RNAi)-mediated gene knockdown experiments to ensure sound conclusions and a reliable scientific knowledge database. H epatitis C virus (HCV) is an enveloped RNA virus in theFlaviviridae family, in which there are seven major genotypes diverging by 30 to 35% at the nucleotide level. Globally, more than 170 million people are infected with HCV, and although 20 to 30% of acute H...

TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP)

“…Since TRIM25 -targeting siRNA #3 was most efficient at rescuing SINV Toto1101/Luc replication, we designed and tested an additional C911 control. The 9 th to 11 th nucleotides of the siRNA were mutated to their complementary sequence, hence the designation C911, to rule out the possibility that the knockdown phenotype was due to the off-target effects of the siRNA [29, 30]. The C911 control should lose its siRNA activity but still maintain its off-target effects as a microRNA.…”

The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action

“…Huh-7.5 or Huh-7.5 CD81 low cells were transfected with viral RNA as previously described (47). Transfection efficiency was enhanced by centrifugation at 2000 rpm, 37°C for 30 min.…”

Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27

“…First, we designed two siRNAs targeting Siglec1 (siR-NA#1 and #2) and determined their knockdown efficiency ( Figure 2A). Both irrelevant (NC) and recently reported C911 seed-matched negative-control siRNA were used to exclude the potential off-target effects of RNA interference [21] (Figure 2A). By measuring the VSV RNA level in the cytoplasm and the 50% tissue culture infective dose (TCID 50 ) per milliliter of the supernatant from the infected macrophages, we found that Siglec1 knockdown suppressed VSV replication ( Figure 2B-2C).…”